Iowa Governor Signs Bill Limiting PBM Practices
SF 383 prohibits PBMs from limiting patient choice of pharmacy, unfairly excluding pharmacies from networks, and forces them to reimburse pharmacies no less than what they pay affiliated pharmacies for the same drug.
Where PBM Reform is Headed in 2025, Beyond | NCPDP 2025
Attorneys from The Phoenix Law Group joined Drug Topics at NCPDP 2025 to discuss the current state of pharmacy benefit manager reform and where it may end up in the near future.
Pharmacy Law Lowdown: PBM Audit Trends, Enforcement Actions
Dae Lee, PharmD, Esq, CPBS and Lucas Morgan, Esq, discuss PBM and board of pharmacy enforcement actions, trends in PBM audits, and more.
How PBMs Impede Pharmacists’ Ability to Perform Clinical Services | APhA 2025
Antonio Ciaccia, President of 3 Axis Advisors, led a discussion on pharmacy benefit manager reform and how the inability to pass legislation has led to increased financial hardships in community pharmacy.
Bipartisan Bill Aims to Combat PBMs’ Medicaid Spread-Pricing
US Senators on both sides of the aisle came together to announce the Protecting Pharmacies in Medicaid Act.
Medicare Drug Price Negotiations Expose Community Pharmacies to Financial Risk
A survey conducted by 3 Axis Advisors revealed potential impacts of the Inflation Reduction Act’s Medicare Drug Price Negotiation Program.
NCPA Joins Class Action Suit Against GoodRx, Industry-Leading PBMs
Along with discount drug card company GoodRx, the suit is aimed at CVS Caremark, Express Scripts, MedImpact Healthcare Systems, and Navitus Health Solutions.
PBMs Significantly Marked Up Specialty Generic Drugs
The Federal Trade Commission released its second interim staff report on industry-leading pharmacy benefit managers and their practices specifically regarding specialty drugs.
Senators Call on FTC to Release Second PBM Report
Ahead of its first general meeting in 2025, lawmakers called on the FTC to vote “yes” on releasing a second interim staff report on PBMs.
DOJ Lawsuit Alleges CVS Helped Fuel Opioid Epidemic Through Unlawful Opioid Prescriptions
The lawsuit alleges that the company knowingly violated both the Controlled Substances Act and the False Claims Act.
Long-Awaited PBM Reform Included in Congress’ End-of-Year Spending Package
The American Pharmacists Association announced the inclusion of pharmacist-backed PBM reform in Congress’ end of the year spending package.
Finish The Fight: Patients Can Push PBM Reform Legislation Over the Finish Line | NCPA 2024
PBM reform legislation has progressed further in Congress than ever before.
Texas Sues Multiple PBMs, Drug Manufacturers Over Inflated Insulin Prices
On October 3,2024, Texas Attorney General Ken Paxton issued the lawsuit, which involves Eli Lilly, Express Scripts, CVS Pharmacy, and other pharmaceutical entities.
Senators Call on FTC to Investigate PBM Co-Manufacturing Tactic
Senators Ron Wyden and Sherrod Brown wrote a letter to the Federal Trade Commission calling to explore yet another PBM tactic impeding competition.
FTC Files Lawsuit Against ‘Big 3’ PBMs for Drug Price Inflation
In its first move since the July interim report detailing pharmacy benefit manager practices, the FTC is now suing CVS Caremark, Express Scripts, and Optum Rx.
How the Big 3 PBMs Utilize Various Market Strategies
To further understand PBM market concentration, researchers separately analyzed commercial insurance, Medicare Part D, and Medicaid managed care market strategies of the 3 biggest PBMs.
Q&A: As Scope of Practice Expands, Technology Must Catch Up
Pharmacists can fill a role for patients, but without technology supporting workflows and reimbursement efforts, challenges will remain.
The Future of Electronic Prescribing Can Help Providers, Pharmacists, and Patients Manage Costs
Through Surescripts, pharmacists can cut down on back-and-forth with prescribers’ offices, saving valuable time for patient care.
Amidst Push for PBM Reform, NACDS Grassroots Efforts Bloom
Inviting members of Congress into the pharmacy helps legislators experience first hand the value that pharmacists bring to their communities.
Video: Legislation, FTC Interim Report Positive Progress in Fight for PBM Reform
Bipartisan support—in a polarized Congress—underscores the importance of pharmacy benefit manager reform.
APhA Campaign Aims to Spread Awareness About Harmful PBM Practices
The American Pharmacists Association is dedicating further time and resources to its ongoing fight for federal PBM reform.
Health Care Costs, Financial Scams Top List of Health Concerns Among Older Adults
Participants were asked to rate their level of concern on 26 health topics.
How PBMs Impact Independent Pharmacies
Tom DePietro, PharmD, owner of DePietro’s Pharmacy in Dunmore, Pennsylvania, discussed his experience as an independent pharmacy owner working under the thumb of pharmacy benefit managers.
Get Into Politics or Get Out of Pharmacy
Our congressional representatives have plenty of interaction with PBM lobbyists. It’s time they hear from patients as well.
Use Your Voice: Pharmacists as Patient Advocates
From expanding vaccination coverage to battling with PBMs, the community pharmacist has the ability to promote change like never before.
Democrats, Republicans Come Together to Condemn PBMs
In a House Committee on Oversight and Accountability hearing, Democrats and Republicans took a bipartisan stance to question the role major PBMs play regarding rising drug costs in the US.
NCPA Representative Discusses Role in Influencing PBM Reform
Steve Postal, JD, Director of Policy and Regulatory Affairs at the National Community Pharmacists Association (NCPA), sat down with Drug Topics to discuss Pharmacy Benefit Managers.
Q&A: What the NCPA is Doing to Fight Back Against PBMs
Steve Postal, JD, Director of Policy and Regulatory Affairs at the National Community Pharmacists Association (NCPA), discussed pharmacy benefit managers and vehicles necessary to induce reform.
PBM Reform Law Aims to Support Local Pharmacies in Pennsylvania
House Bill (HB) 1993 seeks to increase PBM transparency and accountability in an effort to combat the rising cost of prescription drugs.
FTC Issues First Report Regarding Ongoing PBM Inquiry
The FTC released its interim report detailing PBM practices, staggering market consolidation statistics, and the disparities between PBMs and their smaller competitors.
